Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CELLKINE II: BM-MSCs for Lumbar Facet Joint Arthropathies
NCT06001853Phase 2Active, not recruiting
- Sponsor
- Mayo Clinic
- Start
- Nov 2023
- Primary completion
- Dec 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic bone marrow-derived mesenchymal stromal cells in lumbar facet joint arthropathy, low back pain (LBP), sponsored by Mayo Clinic. Started Nov 2023; status: active, not recruiting.
02
Drugs
allogeneic bone marrow-derived mesenchymal stromal cells
03
Conditions
lumbar facet joint arthropathylow back pain (LBP)
Beyond the preview
Go deeper on NCT06001853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06001853.